Abstract
Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.
Original language | English |
---|---|
Pages (from-to) | 261-263 |
Number of pages | 3 |
Journal | Clinical Nuclear Medicine |
Volume | 24 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1999 Apr |
Keywords
- Chemotherapy
- Fluorine-18-2-deoxy-2-fluoro-D-glucose
- Positron Emission Tomography
- Recurrence
- Residue
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging